On February 1, 2022, BrightPath Biotherapeutics Co., Ltd. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
60 JPY | -3.23% | +3.45% | -31.03% |
1st Jan change | Capi. | |
---|---|---|
-31.03% | 27.83M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- 4594 Stock
- News BrightPath Biotherapeutics Co., Ltd.
- BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥1.427175 billion in funding from Macquarie Bank Limited, Investment Arm